🔬
You have used your free lookups for today
Upgrade to BiotechSigns Pro for unlimited company access, full signal history, watchlist alerts, and 125+ PDUFA dates.
Upgrade to Pro →← Back to screener
← Back to Screener
R

RETA

Reata Pharmaceuticals
Rare DiseaseScore: 64/100📋 Full Profile
C
64
Analyst Summary
Verified 2026-04-11

Reata Pharmaceuticals (RETA) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

RETA has 1 Form 4 insider filing recorded at the SEC in the past 30 days[1].

Sources

  1. SEC EDGAR (2026-04-11) ↗
Not financial advice. BiotechSigns scores are for informational purposes only and do not constitute investment recommendations. Always do your own due diligence before making investment decisions.
No active signals for RETA
Signal Summary
PDUFA0
Insider0
Clinical0
Data Sources
DilutionWatch○ PENDING
StonkWhisper○ PENDING
SEC EDGAR● LIVE
ClinicalTrials● LIVE
Yahoo Finance● LIVE